Sunday, 23 August 2026European Markets
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Work with this data → vianewsagency.com

METABOLIC EXPLORER Stock Over 21% Up In The Last 10 Sessions

Loading stream...

(vianews) - shares of metabolic explorer (cac 40: metex.pa) rose by a staggering 21.3% in 10 sessions from €0.98 to €1.19 at 05:06 est on tuesday, after three successive sessions in a row of gains. cac 40 is falling 1.01% to €7,314.05, following the last session's downward trend.

metabolic explorer's last close was €1.19, 72.52% under its 52-week high of €4.33.

about metabolic explorer

metabolic explorer s.a., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. the company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and l-valine. its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. the company was incorporated in 1999 and is based in saint-beauzire, france.

earnings per share

as for profitability, metabolic explorer has a trailing twelve months eps of €-1.14.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -39.56%.

yearly top and bottom value

metabolic explorer's stock is valued at €1.19 at 05:06 est, way under its 52-week high of €4.33 and way above its 52-week low of €0.88.

volatility

metabolic explorer's last week, last month's, and last quarter's current intraday variation average was a negative 0.57%, a positive 0.14%, and a positive 2.82%.

metabolic explorer's highest amplitude of average volatility was 3.04% (last week), 3.01% (last month), and 2.82% (last quarter).

more news about metabolic explorer (metex.pa).